A detailed history of Sweet Financial Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sweet Financial Partners, LLC holds 17,781 shares of ABBV stock, worth $3.2 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
17,781
Previous 18,248 2.56%
Holding current value
$3.2 Million
Previous $3.13 Million 12.21%
% of portfolio
0.79%
Previous 0.74%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$163.84 - $199.33 $76,513 - $93,087
-467 Reduced 2.56%
17,781 $3.51 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $117,176 - $136,835
757 Added 4.33%
18,248 $3.13 Million
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $91,896 - $104,707
575 Added 3.4%
17,491 $3.19 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $270,246 - $304,361
1,964 Added 13.14%
16,916 $2.62 Million
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $192,903 - $223,314
1,444 Added 10.69%
14,952 $2.23 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $455,701 - $567,091
3,439 Added 34.15%
13,508 $1.82 Million
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $1.03 Million - $1.19 Million
7,122 Added 241.67%
10,069 $1.6 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $1,659 - $1,990
-12 Reduced 0.41%
2,947 $0
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $1,610 - $1,847
-12 Reduced 0.4%
2,959 $397,000
Q2 2022

Aug 03, 2022

SELL
$137.62 - $174.96 $2,614 - $3,324
-19 Reduced 0.64%
2,971 $455,000
Q1 2022

Apr 22, 2022

BUY
$131.98 - $163.75 $81,563 - $101,197
618 Added 26.05%
2,990 $485,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $254,823 - $322,425
2,372 New
2,372 $321,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sweet Financial Partners, LLC Portfolio

Follow Sweet Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sweet Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sweet Financial Partners, LLC with notifications on news.